Real-time enrollment status for this sickle cell disease clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 1:47 AM UTC
| NCT Number | NCT02675959 |
| Recruiting Status | Recruiting |
| Condition | Sickle Cell Disease |
| Phase | PHASE2 |
| Target Enrollment | 40 participants |
| Active Locations | 4 sites in the US |
| Sponsor | New York Medical College |
| Last Updated on CT.gov | July 27, 2026 (Jul 27, 2026) |
As of September 1, 2026: Clinical trial NCT02675959 is currently recruiting participants. This phase2 study for sickle cell disease is actively seeking new participants at 4 locations across the United States. The study is sponsored by New York Medical College. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02675959 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02675959 was last updated Jul 27, 2026 (July 27, 2026). HelloStudys verifies this status automatically.